Validation of the iHealth-BP7 and Withings-BP800 blood pressure monitor for self-measurement according to the European Society Hypertension International Protocol revision 2010
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
The purpose of this study is to validate the wireless iHealth-BP7 and Withings-BP800 monitors according to the European Society of Hypertension (ESH) International Protocol revision 2010. Data from 33 participants (30.8 ± 7.3 years) were initially examined according to the ESH International Protocol revision 2010 for the validation of blood pressure (BP) measuring devices. Participants were asked to sit and relax for 10-15 min with legs uncrossed, and back supported prior to the test. In all participants, sequential left arm measurements were performed by two trained observers using a mercury sphygmomanometer, and one supervisor using the device. Collected data were screened according to the ESH protocol for both systolic BP (SBP) and diastolic BP (DBP). The mean differences between the monitor and sphygmomanometer readings were 0.14 ± 6.01 mmHg (SBP) and 0.11 ± 4.99 mmHg (DBP) for the iHealth-BP7 and 3.75 ± 4.61 mmHg (SBP) and 0.28 ± 4.93 mmHg (DBP) for the Withings-BP800. The iHealth-BP7 monitor passed all of the requirements, however, the Withings-BP800 did not meet the second part of the criteria of the ESH international protocol. The iHealth-BP7 monitor is recommended as a valid home BP monitoring device, however, the Withings-BP800 fails to meet the ESH criteria.
Abstract
The purpose of this study is to validate the wireless iHealth-BP7 and Withings-BP800 monitors according to the European Society of Hypertension (ESH) International Protocol revision 2010. Data from 33 participants (30.8 ± 7.3 years) were initially examined according to the ESH International Protocol revision 2010 for the validation of blood pressure (BP) measuring devices. Participants were asked to sit and relax for 10-15 min with legs uncrossed, and back supported prior to the test. In all participants, sequential left arm measurements were performed by two trained observers using a mercury sphygmomanometer, and one supervisor using the device. Collected data were screened according to the ESH protocol for both systolic BP (SBP) and diastolic BP (DBP). The mean differences between the monitor and sphygmomanometer readings were 0.14 ± 6.01 mmHg (SBP) and 0.11 ± 4.99 mmHg (DBP) for the iHealth-BP7 and 3.75 ± 4.61 mmHg (SBP) and 0.28 ± 4.93 mmHg (DBP) for the Withings-BP800. The iHealth-BP7 monitor passed all of the requirements, however, the Withings-BP800 did not meet the second part of the criteria of the ESH international protocol. The iHealth-BP7 monitor is recommended as a valid home BP monitoring device, however, the Withings-BP800 fails to meet the ESH criteria.
참고문헌 (15)
- Alderman, M., "1999 World Health Organization International Society of Hypertension guidelines for the management of hypertension", Blood Pressure, 8, pp.9~43 (1999)
- Belghazi, J., "Validation of four automatic devices for self-measurement of blood pressure according to the International Protocol of the European Society of Hypertension", Vascular health and risk management, 3(4), pp.389~ (2007)
- Blood Pressure Lowering Treatment Trialists' Collaboration, "Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs : results of prospectively designed overviews of randomised trials", The Lancet, 356(9246), pp.1955~1964 (2000)
- Burt, V. L., "Prevalence of hypertension in the US adult population results from the Third National Health and Nutrition Examination Survey, 1988-1991", Hypertension, 25(3), pp.305~313 (1995)
- Chobanian, A. V., "The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure : the JNC 7 report", Jama, 289(19), pp.2560~2571 (2003)
- Coleman, A., "Validation of the Omron MX3 Plus oscillometric blood pressure monitoring device according to the European Society of Hypertension international protocol", Blood pressure monitoring, 10(3), pp.165~168 (2005)
- Coleman, A., "Validation of the Omron 705IT(HEM-759-E)oscillometric blood pressure monitoring device according to the British Hypertension Society protocol", Blood pressure monitoring, 11(1), pp.27~32 (2006)
- Dahlöf, B., "Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study(LIFE) : a randomised trial against atenolol", The Lancet, 359(9311), pp.95~1003 (2002)
- El Assaad, M. A., "Validation of the Omron HEM-907 device for blood pressure measurement", American Journal of Hypertension, 15(S3), pp.87A~87A (2002)
- O'Brien, E., "European Society of Hypertension International Protocol revision 2010 for the validation of blood pressure measuring devices in adults", Blood pressure monitoring, 15(1), pp.23~38 (2010)
- Shang, F., "Validation of the iHealth BP5 wireless upper arm blood pressure monitor for self-measurement according to the European Society of Hypertension International Protocol revision 2010", Blood pressure monitoring, 18(5), pp.278~281 (2013)
- Stamler, J., "Blood pressure, systolic and diastolic, and cardiovascular risks : US population data", Archives of internal medicine, 153(5), pp.598~615 (1993)
- Topouchian, J., "Validation of four devices : Omron M6 Comfort, Omron HEM-7420, Withings BP-800, and Polygreen KP-7670 for home blood pressure measurement according to the European Society of Hypertension International Protocol", Vascular health and risk management, 10, pp.33~ (2014)
- Vasan, R. S., "Impact of high-normal blood pressure on the risk of cardiovascular disease", New England Journal of Medicine, 345(18), pp.1291~1297 (2001)
- Whelton, P. K., "Primary prevention of hypertension : clinical and public health advisory from The National High Blood Pressure Education Program", Jama, 288(15), pp.1882~1888 (2002)